Abstract:
본 발명은 신규 세라마이드 유도체, 이의 제조방법 및 이의 용도에 관한 것으로서, 보다 상세하게는 하기 화학식 2로 표시되는 세라마이드 유도체, 이의 제조방법, 이를 포함하는 화장료 조성물 및 약학적 조성물에 관한 것이다.
상기 식에서, R 1 은 수소 또는 C1-C14의 알킬기이고; R 2 는 수소, 하이드록시기 또는 C1-C11의 알킬기이고; R 3 는 6-메틸 펜타데카-1,5,7-트리엔, 1-하이드록시-노나데카-11-엔 및 노나데카-1,10-다이엔으로 이루어진 군에서 선택되는 어느 하나이고; 및 R 4 는 수소 또는 C1-C6의 알콕시기이다. 세라마이드 유도체, 피부보호, 아폽토시스
Abstract:
A cosmetic composition comprising sargachromenol is provided to induce apoptosis on human keratinocyte significantly, thereby being usefully used in order to prevent and improving skin diseases caused by skin aging, photo-aging and pigmentation. A cosmetic composition for preventing and improving skin diseases comprises sargachromenol represented by a formula(1) and isolated from Sargassum sagamianum as an effective ingredient, wherein the skin disease is a skin disease caused by proliferation of keratinocyte such as skin aging, photo-aging, and a pigmentation disease.
Abstract:
Provided are a ceramide derivative which promotes apoptosis, its preparation method, and a cosmetic composition and a pharmaceutical composition for the treatment of skin disease or cancer containing the derivative or its salt. The ceramide derivative is represented by the formula 2, wherein R1 is H or a C1-C14 alkyl group; R2 is H, a hydroxyl group or a C1-C11 alkyl group; R3 is a 6-methyl-pentadeca-1,5,7-triene group, a 1-hydroxy-nonadeca-11-ene group or a nonadeca-1,11-diene group; and R4 is H or a C1-C6 alkoxy group. The method comprises the steps of extracting a starfish with an organic solvent; concentrating the extract under reduced pressure and fractionating the concentrated one with a solvent mixture of methanol and hexane according to polarity to obtain an active fraction; and separating and purifying the active fraction by chromatography. Preferably the starfish is Distolasterias nipon.
Abstract:
본 발명은 피부질환 및 피부암의 예방 또는 치료용 약학적 조성물에 관한 것이다. 보다 구체적으로, 본 발명은 하기 화학식 I로 표시되는 사가퀴노익산(Sargaquinoic acid)을 유효성분으로 함유하는 피부질환 및 피부암의 예방 또는 치료용 약학적 조성물에 관한 것이다.
Abstract:
A pharmaceutical composition containing Sargaquinoic acid for preventing or treating skin disease and skin cancer is provided to prevent and treat diseases associated with hyperplastic skin cells by inducing cytotoxicity and apoptosis of skin cells, and promotes apoptosis by irradiating ultraviolet rays. A pharmaceutical composition for preventing or treating skin disease and skin cancer contains Sargaquinoic acid represented by the formula(I) or its pharmaceutically acceptable salt as an effective ingredient, wherein the medicinal effects of the pharmaceutical composition are increased by irradiating ultraviolet rays and the skin disease is hyperplastic skin disease including psoriasis, fishskin disease, Bowen's disease, papilloma, eczema, eczema, atopic dermatitis, acne vulgaris, dermatitis, lichen planus, striatus, foot hyperkeratosis, dark spots, actinic keratosis, skin aging and photoaging.